BANGALORE (Reuters) – Dr. Reddy said on Thursday that it has shut down all data center services as a precaution in the wake of a cyber-attack.
Shares of the company, which is partnering to conduct clinical trials of the Russian Sputnik-V COVID-19 vaccine in India, fell as much as 4.3% after local TV channel ET Now first announced the news.
“We expect all services to be operational within the next 24 hours, and we do not expect any significant impact on our operations due to this incident” Mukesh Rathi, Chief Information Officer at Dr. Reddy Laboratories, said in a special statement.
Dr. Reddy Laboratories, India’s No. 2 pharmaceutical company by market value, has suspended their major factories globally due to a hack in its servers, ET Now reported, citing sources.
The report added that Dr. Reddy’s factories in the United States, the United Kingdom, Brazil, India and Russia were affected by the isolation.
Dr. Reddy Laboratories, based in Hyderabad, has partnerships with global companies to sell remdesivir and favipiravir vaccines in India in addition to its partnership in the Sputnik-V vaccine.